
Academic Journal
Q1Current Opinion in Infectious Diseases
About Current Opinion in Infectious Diseases
About Current Opinion in Infectious Diseases
Current Opinion in Infectious Diseases is a peer-reviewed scholarly journal published by Lippincott Williams and Wilkins (United States). It focuses on Q1. Publication coverage spans 1988-2026.
Key indicators: ISSN 0951-7375, 1473-6527; H-index 127.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (127): Exceptionally high — 127 articles have each been cited at least 127 times. This indicates deep, sustained influence in the field.
Publishing in Current Opinion in Infectious Diseases
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Current Opinion in Infectious Diseases?
0951-7375, 1473-6527.
Who publishes Current Opinion in Infectious Diseases?
Lippincott Williams and Wilkins.
What are Current Opinion in Infectious Diseases's metrics?
H-index 127.
Is Current Opinion in Infectious Diseases peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Fungal Infections and Studies; Antifungal resistance and susceptibility; Nosocomial Infections in ICU; Cytomegalovirus and herpesvirus research; Pneumonia and Respiratory Infections; Respiratory viral infections research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Reducing antibiotic burden in gram-negative bacteraemia: duration optimization and early oral transition
Renato Pascale, Matteo Montironi, Maddalena Giannella
2026-10-12 · DOI: 10.1097/qco.0000000000001242Screening for multidrug-resistant organism: clinical benefit or unquestioned routine
Alex Soriano, Marta Ulldemolins, Cristina Pitart, Pedro Castro et al.
2026-10-12 · DOI: 10.1097/qco.0000000000001248Clinical and genetic risk factors for apolipoprotein L1-mediated chronic kidney disease in people of African ancestry with HIV
Frank A. Post, Dami Collier, Cheryl A. Winkler
2026-10-12 · DOI: 10.1097/qco.0000000000001253Severe strongyloidiasis and Gram-negative bacterial superinfections: epidemiology, clinical implications, and therapeutic strategies
Chiara Sepulcri, Antonio Vena, Matteo Bassetti
2026-10-09 · DOI: 10.1097/qco.0000000000001249Managing KPC infections in daily practice: when BLBLIs are interchangeable – and when they are not
Vasiliki Rapti, Ilias Karaiskos, Garyfallia Poulakou
2026-10-09 · DOI: 10.1097/qco.0000000000001238Endemic Mycoses in 2026: can we keep the pace of redrawing maps?
Marcela Araujo de Oliveira Santana, Julio C. Zuniga-Moya, Cody Cunningham, Adriana M. Rauseo et al.
2026-09-18 · DOI: 10.1097/qco.0000000000001244Adenovirus infection after cellular therapy: diagnostic and therapeutic challenges
Natalie Yap, Nelson Y. Wang, Michelle K. Yong, Gabrielle M. Haeusler et al.
2026-09-18 · DOI: 10.1097/qco.0000000000001245Fungal diseases in burn and blast-injured patients: tensions are rising, and awareness must keep pace
Emmanuel Dudoignon, Rania Mhenni, Sarah Dellière
2026-09-02 · DOI: 10.1097/qco.0000000000001241Rates of azole resistance in aspergillosis: a worldwide overview
Nathan P. Wiederhold
2026-08-27 · DOI: 10.1097/qco.0000000000001235Using bacteriophage cocktails in MDR Gram-negative infections: a practical manual
Jennifer M. Dan
2026-08-27 · DOI: 10.1097/qco.0000000000001237Machine learning to differentiate colonization from infection in multidrug-resistant Gram-negative bacteria: implications for further research
Daniele Roberto Giacobbe, Elena Ceccardi, Lucia Scarfone, Marco Muccio et al.
2026-08-27 · DOI: 10.1097/qco.0000000000001240Antiviral targets in the prevention and treatment of measles
Sebastian Ortiz Colmenares, Cole Sher-Jan, Christian K. Pfaller
2026-08-27 · DOI: 10.1097/qco.0000000000001239Editorial introductions
2026-10 · DOI: 10.1097/qco.0000000000001233Emergence of alveolar echinococcosis in Canada: a warning for the USA
Stephen D. Vaughan, Jamie L. Rothenburger, Kinga Kowalewska-Grochowska
2026-10 · DOI: 10.1097/qco.0000000000001229Management of neonates born to mothers with reactive serologic tests for syphilis
Abigail Z. Nishikawa, W. Christopher Golden, Alexa J. Brumfiel, Sameer B. Chand et al.
2026-10 · DOI: 10.1097/qco.0000000000001234Alveolar echinococcosis
Marija Stojković, Thomas Junghanss, Kim G. Gehling
2026-10 · DOI: 10.1097/qco.0000000000001226A review into the recent advances in the world of amoebiasis
Louis Egerton, Gauri Godbole
2026-10 · DOI: 10.1097/qco.0000000000001236Recent advances in Strongyloides screening, diagnostics, therapeutics, and management
Eva H. Clark, Thomas B. Nutman
2026-10 · DOI: 10.1097/qco.0000000000001217Evolving paradigms in pediatric osteomyelitis: modern insights into an old disease
Jesús Saavedra-Lozano, Marta Agüera, Eneritz Velasco-Arnaiz
2026-10 · DOI: 10.1097/qco.0000000000001231Novel antifungal agents for treating endemic mycoses: hope on the horizon?
Nathan C. Bahr, Alessandro C. Pasqualotto, George R. Thompson
2026-08-06 · DOI: 10.1097/qco.0000000000001225Reviews
Community Reviews
Version History
October 9, 2026 at 7:47 pm
September 25, 2026